Cargando…

Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer

KRAS activating mutations, which are present in more than 90% of pancreatic cancers, drive tumor dependency on the RAS/mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT signaling pathways. Therefore, combined targeting of RAS/MAPK and PI3K/AKT signaling pathways may be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji Eun, Woo, Min Gyu, Jung, Kyung Hee, Kang, Yeo Wool, Shin, Seung-Min, Son, Mi Kwon, Fang, Zhenghuan, Yan, Hong Hua, Park, Jung Hee, Yoon, Young-Chan, Kim, Yong-Sung, Hong, Soon-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047487/ https://www.ncbi.nlm.nih.gov/pubmed/34663758 http://dx.doi.org/10.4062/biomolther.2021.145

Ejemplares similares

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer
por: Park, Jung Hee, et al.
Publicado: (2017)

HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer
por: Rumman, Marufa, et al.
Publicado: (2016)

Crizotinib Exhibits Antitumor Activity by Targeting ALK Signaling not c-MET in Pancreatic Cancer
por: Yan, Hong Hua, et al.
Publicado: (2014)

The walnut genetic resources of INRA: chronological phenotypic data and ontology
por: Bernard, Anthony, et al.
Publicado: (2019)

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis
por: Kim, Juyoung, et al.
Publicado: (2020)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

Deamidated gluten: specific detection and characterisation with INRA-DG1 mAb
por: Tranquet, Olivier, et al.
Publicado: (2015)

“Interactive Technology Assessment” and Beyond: the Field Trial of Genetically Modified Grapevines at INRA-Colmar
por: Lemaire, Olivier, et al.
Publicado: (2010)

INRA, a new high-frequency antigen in the INDIAN (IN023) blood group system
por: Joshi, Sanmukh R., et al.
Publicado: (2017)

Modelling Nutritional Requirements of Growing Pigs from Local Breeds Using InraPorc
por: Brossard, Ludovic, et al.
Publicado: (2019)

Cordyceps militaris Grown on Germinated Soybean Suppresses KRAS-Driven Colorectal Cancer by Inhibiting the RAS/ERK Pathway
por: Seo, HeeJung, et al.
Publicado: (2018)

HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
por: Son, Mi Kwon, et al.
Publicado: (2013)

cdc37 is essential for JNK pathway activation and wound closure in Drosophila
por: Lee, Chan-wool, et al.
Publicado: (2019)

Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer
por: Zhang, Xiaofei, et al.
Publicado: (2022)

ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a
por: Jung, Kyung Hee, et al.
Publicado: (2020)

Genome Sequence of the Emerging Mycotoxin-Producing Filamentous Fungus Fusarium tricinctum Strain INRA104
por: Ponts, Nadia, et al.
Publicado: (2018)

The INRAE Centre for Vegetable Germplasm: Geographically and Phenotypically Diverse Collections and Their Use in Genetics and Plant Breeding
por: Salinier, Jérémy, et al.
Publicado: (2022)

HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation
por: Kim, Soo Jung, et al.
Publicado: (2014)

Activation of KRAS promotes the mesenchymal features of basal-type breast cancer
por: Kim, Rae-Kwon, et al.
Publicado: (2015)

Quantitative trait loci linked to PRNP gene controlling health and production traits in INRA 401 sheep
por: Vitezica, Zulma G, et al.
Publicado: (2007)

A Global Analysis of Y-STR INRA189 Polymorphism in Chinese Domestic Yak Breeds/Populations
por: Ma, Zhijie, et al.
Publicado: (2020)

Contribution of nutrient fluxes to the evolution of the net energy systems, example of the INRA feeding system for beef cattle
por: Ortigues-Marty, Isabelle, et al.
Publicado: (2019)

Targeting the PI3K signaling pathway in KRAS mutant colon cancer
por: Hong, Suntaek, et al.
Publicado: (2015)

Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties
por: Hong, Sungwoo, et al.
Publicado: (2018)

Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer
por: Nam, Gi-Hoon, et al.
Publicado: (2021)

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations
por: Moon, Jai-Hee, et al.
Publicado: (2019)

Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/MAPK Pathway of Hepatic Stellate Cells
por: Yoon, Young-Chan, et al.
Publicado: (2020)

Matrine suppresses KRAS‐driven pancreatic cancer growth by inhibiting autophagy‐mediated energy metabolism
por: Cho, Young‐ra, et al.
Publicado: (2018)

Does Ras Activate Raf and PI3K Allosterically?
por: Nussinov, Ruth, et al.
Publicado: (2019)

YM155 Induces EGFR Suppression in Pancreatic Cancer Cells
por: Na, Young-Soon, et al.
Publicado: (2012)

MEK blockade overcomes the limited activity of palbociclib in head and neck cancer
por: Fang, Zhenghuan, et al.
Publicado: (2020)

Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer
por: Cheng, Derek K., et al.
Publicado: (2021)

Analgesic effect of structured anal skin care for perianal dermatitis after low anterior resection in the rectal cancer patients: prospective, single-center, open-label, therapeutic confirmatory, randomized clinical trial
por: Son, Gyung Mo, et al.
Publicado: (2022)

Données complémentaires sur les besoins nutritionnels de la reproductrice naine « Vedette I.N.R.A. JV 15 »
por: Guillaume, J
Publicado: (1971)

Testosterone Protects Pancreatic β-cells from Apoptosis and Stress-Induced Accelerated Senescence
por: Kang, Seon Mee, et al.
Publicado: (2021)

KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
por: Vendramini, Elena, et al.
Publicado: (2022)

Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022)

A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab
por: Lee, Sang-Kyu, et al.
Publicado: (2018)

Annotation data about multi criteria assessment methods used in the agri-food research: The french national institute for agricultural research (INRA) experience
por: Gésan-Guiziou, Geneviève, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ri06kmdngm8hh1seg37b2ofr6s